Clinical Trial Update: An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis [EARLY_Phase 1]

View source ↗

Summary

An investigator-initiated, open-label Phase 1 trial evaluating the efficacy and tolerability of oral deucravacitinib for nail psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nail Psoriasis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Nail Psoriasis | EARLY_Phase 1 | Status: COMPLETED